While glutathione is approved for certain medical applications, its use for cosmetic enhancement remains off-label, placing responsibility on providers and patients to navigate potential risks without regulatory guidance
Research has shown that phosphoglycerate dehydrogenase (PHGDH), the enzyme that catalyzes the first reaction in the serine synthesis pathway, was highly upregulated in metastatic breast cancer and was correlated to short patient survival times [135, 136]
doi:10.1016/j.bbagen.2012.09.008
This imbalance can lead to issues like fatigue, weaker immunity, and accelerated aging
However, mutations in the MTHFR gene typically result in a lack of folate required for methylation reactions
The benefits described are based on third-party studies